Identification of microRNA Expression Patterns in Cutaneous and Uveal Melanoma Cell Lines

Aims and Background microRNA (miRNA)-mediated epigenetic regulation of tumor suppressor genes and oncogenes has been shown to play a central role in melanomagenesis. Here, we focused on the identification of miRNA signatures in the cutaneous melanoma cell line G361 and the uveal melanoma cell line OCM-1. Methods and Study Design We carried out genome-wide miRNA expression profiling using a human miRNA microarray platform (Agilent Sanger miRBase, release 10.1) in both cell lines. Results Our screening revealed significant alteration of miRNA expression profiles in melanoma cell lines compared with normal human epidermal melanocytes. We defined 208 differentially expressed miRNAs in OCM-1 and 112 in G361. By comparison analysis between the resulting miRNA expression profiles, we identified 96 miRNAs that were modified in both cell models. Among these commonly modified miRNAs, 65 were downregulated, 28 upregulated, and 3 exhibited a different expression trend. Conclusions Although preliminary, our analysis identified new melanoma-associated miRNAs providing novel miRNA candidates for the development of anticancer target therapy.

[1]  A. Bosserhoff,et al.  MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression , 2013, Oncogene.

[2]  D. Teti,et al.  Class II‐specific histone deacetylase inhibitors MC1568 and MC1575 suppress IL‐8 expression in human melanoma cells , 2013, Pigment cell & melanoma research.

[3]  A. Chinnaiyan,et al.  Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma , 2012, Oncotarget.

[4]  R. Navon,et al.  Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor , 2012, Molecular Cancer.

[5]  L. Poliseno,et al.  Histology-specific microRNA alterations in melanoma. , 2012, The Journal of investigative dermatology.

[6]  D. Teti,et al.  Combined effects of cigarette smoking and alcohol consumption on antioxidant/oxidant balance in age-related macular degeneration , 2012, Aging Clinical and Experimental Research.

[7]  H. Suemizu,et al.  Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene. , 2012, Experimental and therapeutic medicine.

[8]  R. Maria,et al.  The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms , 2012, Journal of Molecular Medicine.

[9]  J. Zavadil,et al.  miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. , 2011, Cancer cell.

[10]  S. Bondanza,et al.  MicroRNA‐155 targets the SKI gene in human melanoma cell lines , 2011, Pigment cell & melanoma research.

[11]  D. Hu,et al.  Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma. , 2011, Investigative ophthalmology & visual science.

[12]  Y. Inoue,et al.  The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. , 2011, Journal of dermatological science.

[13]  A. de Klein,et al.  Genetics of Uveal Melanoma and Cutaneous Melanoma: Two of a Kind? , 2010, Dermatology research and practice.

[14]  R. Gutzmer,et al.  MicroRNA‐15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma , 2010, International journal of cancer.

[15]  Xudong Dai,et al.  MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT , 2009, Cell cycle.

[16]  Bin Wang,et al.  Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. , 2009, Oncology reports.

[17]  D. Hu,et al.  MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. , 2009, Investigative ophthalmology & visual science.